Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nebulette is a cardiac-specific protein in the nebulin family, encoded by the NEBL gene. It is primarily expressed in cardiac muscle, where it binds actin and interacts with thin filaments and Z-line–associated proteins in striated muscle. Nebulette is essential for organizing and maintaining the structural integrity of myofibrils, especially at the Z-disk, and is involved in the assembly and stabilization of cardiac myofibrils[1][3]. It interacts with key cytoskeletal and focal adhesion proteins including zyxin, filamin C, Xin, α-actinin, tropomyosin, troponin T, and myopalladin[2][1]. Alternative splicing results in multiple isoforms, including LIM-nebulette, which is found in non-muscle cells and may be a component of focal adhesion complexes[3]. Mutations in NEBL result in various cardiomyopathies and other pathologies, highlighting its critical role in cardiac biology and disease[2][1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nebulette (NEBL).